Skip to main content

Advertisement

SpringerLink
Log in

Impact and prognostic implications of colon cancers stage II sub-classification through the years

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

According to the American Joint Committee on Cancer (AJCC) 7th edition, T4 colon cancers have been sub-divided into T4a and T4b, resulting in a stage II sub-classification (T3N0, T4aN0, and T4bN0). This study was aimed: (a) to investigate the impact of the AJCC 7th edition stage II sub-classification on the overall survival (OS), disease-free survival (DFS) and disease-specific survival (DSS) of colon cancer patients who underwent surgical resection and (b) to compare the last three AJCC editions for identifying stage II patients with high-risk of progression.

Methods

One hundred seventy-eight stage II colon cancers out of 682 colorectal cancer patients who underwent surgical resection were selected. T4N0 were sub-divided in accordance with the AJCC 7th edition. Mean follow-up was 41.9 months. Kaplan–Meier method was employed to estimate the survival curves.

Results

OS analysis documented a significant difference between stage-sub-groups using the 6th edition; conversely, this difference was not seen if the 7th edition was applied (p = 0.03 and 0.12, respectively). Stage II DFS analysis reported a significant difference using both the AJCC 6th and 7th editions (p = 0.03 and 0.02, respectively). A significant difference was reported on stage II DSS analysis using the AJCC 6th edition (p = 0.03); however, when the 7th edition was applied, a substantial discrepancy between survival curves was noted with T3N0 and T4aN0 displaying similar outcomes (p = 0.006).

Conclusions

The AJCC 7th edition is a reliable classification that might implement the identification of those stage II colon cancer patients with high-risk of progression, recurrence, and cancer mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. American Joint Committee on Cancer (1977) Manual for staging of cancer, 1st edn. American Joint Committee on Cancer, Chicago

    Google Scholar 

  2. TNM Classification of malignant tumors, 2nd edition; International Union Against Cancer, 3 rue du Conseil-General, 1205 Geneva, Switzerland

  3. American Joint Committee on Cancer (1983) Manual for staging of cancer, 2nd edn. Lippincott, Philadelphia

    Google Scholar 

  4. American Joint Committee on Cancer (1988) Manual for staging of cancer, 3rd edn. Lippincott, Philadelphia

    Google Scholar 

  5. American Joint Committee on Cancer (1997) Manual for staging of cancer, 5th edn. Lippincott, Philadelphia

    Google Scholar 

  6. American Joint Committee on Cancer (2002) Manual for staging of cancer, 6th edn. Springer, Berlin

    Google Scholar 

  7. Colorectal Working Group, Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP (2000) American Joint Committee on Cancer prognostic factors consensus conference. Cancer 88(7):1739–1757

    Article  PubMed  CAS  Google Scholar 

  8. Sheperd N, Baxter K, Love S (1997) The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 112:1096–1102

    Article  Google Scholar 

  9. Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK (2009) Revised TN categorization for colon cancer based on national survival outcome data. J Clin Oncol 28(2):264–271

    Article  PubMed  Google Scholar 

  10. Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK (2009) Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology and end result and rectal pooled analysis outcomes. J Clin Oncol 28(2):256–263

    Article  PubMed  Google Scholar 

  11. American Joint Committee on Cancer (2009) Manual for staging of cancer, 7th edn. Springer, Berlin

    Google Scholar 

  12. Gunderson LL, Sargent DJ, Tepper JE, O’Connel MJ, Allmer C, Smalley SR, Martenson JA, Haller DG, Mayer RJ, Rich TA, Ajani JA, Macdonald JS, Goldberg RM (2002) Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis. Int J Radiat Oncol Biol Phys 54(2):386–396

    Article  PubMed  Google Scholar 

  13. Gunderson LL, Sargent DJ, Tepper JE, Wolmark N, O’Connell MJ, Begovic M, Allmer C, Colangelo L, Smalley SR, Haller DG, Martenson JA, Mayer RJ, Rich TA, Ajani JA, Macdonald JS, Willett CG, Goldberg RM (2004) Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 22(10):1785–1796

    Article  PubMed  Google Scholar 

  14. Gollis S (2010) Radiotherapy, chemotherapy and biological therapy in the curative treatment of locally advantage rectal cancer. Color Dis 12(Supp 2):2–24

    Article  Google Scholar 

  15. Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A (1998) Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum 41(9):1127–1133

    Article  PubMed  CAS  Google Scholar 

  16. Rodriguez-Moranta F, Salo J, Arcusa A, Boadas J, Piñol V, Bessa X, Batiste-Alentorn E, Lacy AM, Delgado S, Maurel J, Piqué JM, Castells A (2006) Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol 24(3):386–393

    Article  PubMed  Google Scholar 

  17. Secco GB, Fardelli R, Gianquinto D, Bonfante P, Baldi E, Ravera G, Derchi L, Ferraris R (2002) Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 28(4):418–423

    Article  PubMed  Google Scholar 

  18. Swamy R (2010) Histopathological reporting of pT4 tumor stage in colorectal carcinomas: dotting the ‘i’s and crossing the ‘t’s. J Clin Pathol 63:110–115

    Article  PubMed  CAS  Google Scholar 

  19. National Comprehensive Cancer Network (NCCN) Clinical practice guidelines in oncology (NCCN Guidelines™). Colon Cancer. Version 3.2011. Available from: http//:www.nccn.org

  20. Benson AB, Shrag D, Somerfield MR, Cohen AM, Figuredo AT, Flynn PJ, Kryzanowska MK, Maroun J, McAllister P, Van Custem E, Brouwers M, Charette M, Haller DG (2004) American Society of Clinical Oncology Recommendations on adjuvant Chemotherapy for Stage II colon cancer. J Clin Oncol 22(16):3408–3419

    Article  PubMed  Google Scholar 

  21. Gill S, Loprizi CL, Sargent DJ, Thomè SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Seitz JF, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM (2004) Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22(10):1797–1806

    Article  PubMed  CAS  Google Scholar 

  22. Greene FL, Stewart AK, Norton J (2002) A new TNM staging strategy for node-positive (stage III) colon cancer. An analysis of 50.042 patients. Ann Surg 236(4):416–421

    Article  PubMed  Google Scholar 

  23. Saergent D, Sobrero A, Grothey A, O’Connell MJ, Buyse M, Andre T, Zheng Y, Green Em Labianca R, O’Callaghan C, Seitz JF, Francini G, Haller D, Yothers G, Goldeberg R, de Gramont A (2009) Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 27(6):872–877

    Article  Google Scholar 

Download references

Funding

Laura Lorenzon and Marco La Torre are supported by the Ph.D. University Grant program “Clinical and Experimental Research Methodologies in Oncology” provided by the Faculty of Medicine and Psychology University of Rome “La Sapienza.”

Competing interests

None of the authors have any potential financial conflict of interest related to this manuscript.

Author information

Authors and Affiliations

  1. Surgical and Medical Department of the Clinical Sciences, Biomedical Technologies and Translational Medicine, Sant’Andrea Hospital, Faculty of Medicine and Psychology University of Rome “La Sapienza”, Via di Grottarossa 1035-39, 00189, Rome, Italy

    Laura Lorenzon, Marco La Torre, Vincenzo Ziparo & Mario Ferri

  2. Department of Clinical and Molecular Medicine, Sant’Andrea Hospital, Faculty of Medicine and Psychology University of Rome “La Sapienza”, Rome, Italy

    Emanuela Pilozzi

Authors
  1. Laura Lorenzon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emanuela Pilozzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marco La Torre
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vincenzo Ziparo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mario Ferri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laura Lorenzon.

Additional information

Authorship: all authors contributed in preparing the manuscript; all authors have reviewed and approved the manuscript in its final form.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lorenzon, L., Pilozzi, E., La Torre, M. et al. Impact and prognostic implications of colon cancers stage II sub-classification through the years. Int J Colorectal Dis 27, 1311–1318 (2012). https://doi.org/10.1007/s00384-012-1475-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-012-1475-x

Keywords

Search

Navigation